PMC:7161517 / 3503-3656 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T34","span":{"begin":108,"end":131},"obj":"Disease"}],"attributes":[{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"}],"text":"s (ARBs), and mineralocorticoid receptor antagonists (MRAs) has been critical for the management of various cardiovascular diseases. In the last 2 decade"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T24","span":{"begin":60,"end":63},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"s (ARBs), and mineralocorticoid receptor antagonists (MRAs) has been critical for the management of various cardiovascular diseases. In the last 2 decade"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T38","span":{"begin":14,"end":31},"obj":"Chemical"},{"id":"T39","span":{"begin":41,"end":52},"obj":"Chemical"}],"attributes":[{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_25354"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"}],"text":"s (ARBs), and mineralocorticoid receptor antagonists (MRAs) has been critical for the management of various cardiovascular diseases. In the last 2 decade"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":108,"end":131},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0001626"}],"text":"s (ARBs), and mineralocorticoid receptor antagonists (MRAs) has been critical for the management of various cardiovascular diseases. In the last 2 decade"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T102","span":{"begin":14,"end":31},"obj":"CHEBI:25354;CHEBI:25354"},{"id":"T103","span":{"begin":32,"end":52},"obj":"CHEBI:48561;CHEBI:48561"},{"id":"T104","span":{"begin":108,"end":122},"obj":"UBERON:0004535"}],"text":"s (ARBs), and mineralocorticoid receptor antagonists (MRAs) has been critical for the management of various cardiovascular diseases. In the last 2 decade"}

{"project":"LitCovid-PubTator","denotations":[{"id":"113","span":{"begin":14,"end":40},"obj":"Gene"},{"id":"147","span":{"begin":108,"end":131},"obj":"Disease"}],"attributes":[{"id":"A113","pred":"tao:has_database_id","subj":"113","obj":"Gene:4306"},{"id":"A147","pred":"tao:has_database_id","subj":"147","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"s (ARBs), and mineralocorticoid receptor antagonists (MRAs) has been critical for the management of various cardiovascular diseases. In the last 2 decade"}